VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Healthcare Medical Devices

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd

<< Previous

Bullboard Posts

Next >>

Post by jopatcloon Sep 20, 2024 12:52pm

39 Views

Post# 36233393

BSEcho 2024 📅 Friday 11 + Saturday 12 October 2024

Interesting BSEcho2024 Interesting Remenber Where has Hugh been lately Hugh in London maybe news Collaborations or Partnerships ? Very excited to have next messages from Dear friends of Dr. Adams the visionary with Ventripoint. (Sales or FDA V4.0) its going up Reminder of July 5, 2023 Ventripoint Diagnostics Makes Significant Sale to the Largest Heart Center in Germany (July 4 = low 0.13 and July 24 = high 0.325 )

Have you seen our BSEcho2024 hands-on sessions yet? Our industry partners GE HealthCare are covering lots of great topics limited spaces available

Already registered? Just head to the bottom of the booking page to add the sessions to your itinerary: https://ow.ly/EKkX50Tq7fB